Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
71 studies found for:    "Tobacco, Smokeless" | Open Studies
Show Display Options
Download search resultsDownload the search results for:
"Tobacco, Smokeless" | Open Studies (71 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Metabolism of Deuterated NNN in Smokeless Tobacco Users
Condition: Tobacco Toxicant Exposure
Intervention: Drug: Deuterated NNN
2 Recruiting A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
Condition: Tobacco Use Cessation
Intervention: Behavioral: Multimedia Support Intervention
3 Recruiting Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention
Condition: Smokeless Tobacco Cessation
Interventions: Behavioral: Scheduled Gradual Reduction (SGR);   Behavioral: Text Messages
4 Not yet recruiting Labeled Nornicotine in Smokeless Tobacco
Condition: Tobacco Toxicity
Interventions: Drug: [D4]Nornicotine - Highest;   Other: [D4]Nornicotine - Mean;   Other: [D4]Nornicotine - Lowest;   Other: [D4]Nornicotine - 50% Lowest;   Other: [D4]Nornicotine - 10% Lowest;   Other: [D4]Nornicotine - 5% Lowest;   Other: 13C6-NNN;   Other: Herbal Snuff
5 Not yet recruiting Continuous Wound Infiltration for Diminution of Post-surgery Pain After Caesarean Section
Condition: Pain
Intervention: Drug: Ropivacaine
6 Recruiting Prevention of Alcohol Related Incidents in Air Force Technical Training
Condition: Alcohol Abuse
Intervention: Behavioral: Group Brief Alcohol Intervention
7 Recruiting Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products
Condition: Adverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial Encounter
Interventions: Other: Cigarette, NIDA test type with 16.6 mg nicotine;   Other: Cigarette, NIDA test type with <0.45 mg nicotine;   Other: Electronic cigarette with 18 mg/ml nicotine;   Other: Electronic Cigarette with no nicotine;   Other: Moist snuff;   Other: sham smoking;   Other: Secondhand cigarette smoke (SHS);   Other: Conditioned, filtered air;   Other: sham moist snuff
8 Recruiting Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism
Conditions: Secondary Parkinsonism;   Parkinson's Disease
Intervention: Other: no intervention
9 Recruiting CHANGE Feasibility Study
Condition: Hearing Loss
Intervention: Device: Nucleus CI532 cochlear implant
10 Recruiting Physiotherapy Prehabilitation in Patients Undergoing Cardiac or Thoracic Surgery
Conditions: Coronary Artery Disease;   Lung Cancer;   Lung Tumor
Interventions: Other: Walking Programme;   Device: Incentive Spirometer;   Other: Deep Breathing Exercises
11 Recruiting Impact of Monitoring Quality Indicators in Maternity Departments on Mother and Infant Health
Conditions: Obstetric; Injury;   Injury
Intervention: Other: CUmulative SUM (CUSUM) Chart
12 Recruiting Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai
Condition: Compliance
Interventions: Behavioral: Tobacco users;   Drug: Pharmacotherapy
13 Recruiting Community Intervention to Reduce Tobacco Use in Pregnant Women
Condition: Nicotine Dependence
Intervention: Behavioral: Community level intervention
14 Not yet recruiting Diabetes and Palliative Care
Conditions: End-of-life;   Diabetes;   Terminal Cancer
Intervention: Other: diagnosis
15 Not yet recruiting The Analgesic Activity of a Topical Formulation in Patients With Osteoarthritis of the Hands
Condition: Osteoarthritis of the Hands
Interventions: Drug: A/B;   Drug: Placebo;   Drug: B/A
16 Recruiting Analysis of TCLT in TBI Patients: a Prospective, Randomized Controlled Trial
Conditions: Brain Injury;   Cognitive Deficits
Interventions: Device: Transcranial LED Therapy (TCLT);   Device: Sham
17 Not yet recruiting Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
Condition: Type 2 Diabetes
Intervention: Drug: Evogliptin, Pioglitazone, Evogliptin+Pioglitazone
18 Recruiting Retrospective Evaluation of CML Patients in the National Compassionate Program
Conditions: Chronic Myeloid Leukemia;   Philadelphia Positive
Intervention: Drug: Ponatinib
19 Recruiting Generalized Neonatal Screening of Severe Combined Immunodeficiencies
Condition: Severe Combined Immunodeficiency, Atypical
Intervention: Biological: SCID screening
20 Recruiting Thermic Effects of Some Scottish Plant Foods
Conditions: Diet Induced Thermogenesis;   Obesity Control
Interventions: Dietary Supplement: Control Meal;   Dietary Supplement: Berry Treatment;   Dietary Supplement: Sea Buckthorn Treatment;   Dietary Supplement: Wild Garlic Treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.